» Articles » PMID: 32502579

Regulation of JNK Signaling Pathway and RIPK3/AIF in Necroptosis-mediated Global Cerebral Ischemia/reperfusion Injury in Rats

Overview
Journal Exp Neurol
Specialty Neurology
Date 2020 Jun 6
PMID 32502579
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Receptor-interacting protein kinase 3 (RIPK3) regulates a newly discovered cell death form called necroptosis. RIPK3 nuclear translocation and inflammatory factor release are involved in necroptosis after rat global cerebral ischemia/reperfusion (I/R) injury. The purpose of this study was to investigate the effects of interactions between the RIPK3 and apoptosis-inducing factor (AIF) necroptosis pathway and the JNK-mediated inflammatory pathway. Rats were subjected to 4-vessel occlusion and reperfusion injury. RIPK3 inhibitor GSK872, RIPk3 recombinant adeno-associated virus (rAAV) and JNK-specific inhibitor SP600125 were intracerebroventricular injected before I/R. Hippocampus CA1 tissue were obtained and RIPK3, AIF, p-JNK, IL-6 were determined by western blot analysis. The RIPK3 and AIF interaction were also analyzed by immunofluorescence and immunoprecipitation. The expression of endogenous RIPK3, AIF, p-JNK and IL-6 was increased in hippocampus CA1 in I/R group. In addition, RIPK3 was increased in both the total protein and nuclear protein. GSK872 administration reduced the number of neuron deaths and the expression of RIPK3, p-JNK and IL-6. GSK872 also improve the rat neurobehavior. While use RIPk3 rAAV treatment to overexpress RIPK3, it appeared lower neuron survival. Immunofluorescence staining demonstrated that RIPK3 and AIF formed as a novel complex in the cytoplasm first, and then nuclear translocation. GSK872 pretreatment decreased the number of RIPK3-positive cells and related to the generation of RIPK3-AIF complex in nuclear. Moreover, the production of inflammatory factors levels was found to be significantly elevated after I/R. We further use SP600125 to attenuate inflammation cascade. It not only inhibits the expression of inflammatory factors p-JNK and IL-6, but also inhibits RIPK3 and AIF in the cytoplasm. Collectively, the results of our study indicate that RIPK3-mediated necroptosis interacts with the JNK-mediated inflammatory signaling pathway to participate in global cerebral I/R injury. JNK-regulated inflammatory mediators may promote the necroptosis initiation.

Citing Articles

Advances in the Study of Necroptosis in Vascular Dementia: Focus on Blood-Brain Barrier and Neuroinflammation.

Qiu Y, Cheng L, Xiong Y, Liu Z, Shen C, Wang L CNS Neurosci Ther. 2025; 31(2):e70224.

PMID: 39915907 PMC: 11802338. DOI: 10.1111/cns.70224.


Insight into interplay between PANoptosis and autophagy: novel therapeutics in ischemic stroke.

Tian H, Lei Y, Zhou J, Liu L, Yang T, Zhou Y Front Mol Neurosci. 2025; 17():1482015.

PMID: 39846000 PMC: 11751022. DOI: 10.3389/fnmol.2024.1482015.


Gentiopicroside-Induced gastric cancer necroptosis via the HIF-1 signaling pathway: A study involving molecular docking and experimental validation.

Xiong B, Fan M, Wang Z, Yang X, Cao S, Shen J PLoS One. 2024; 19(11):e0311152.

PMID: 39570876 PMC: 11581292. DOI: 10.1371/journal.pone.0311152.


Inhibiting H2AX Can Ameliorate Myocardial Ischemia/Reperfusion Injury by Regulating P53/JNK Signaling Pathway.

Yu Z, Teng Y, Yang H, Wang Y, Li X, Feng L Cardiol Res Pract. 2024; 2024:1905996.

PMID: 39257436 PMC: 11387088. DOI: 10.1155/2024/1905996.


Natural herbal extract roles and mechanisms in treating cerebral ischemia: A systematic review.

Yang J, Yu B, Zheng J Front Pharmacol. 2024; 15:1424146.

PMID: 39156109 PMC: 11327066. DOI: 10.3389/fphar.2024.1424146.